He explains the rationale for combining GLP-1 and glucagon for MASH, and discusses 24-week data that was released earlier this year. 48-week data will be coming in the fourth quarter, as well as a meeting with FDA.
Coverage brought to you by:
Also look for unique social pages for BiotechTV U.
HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.
Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.
.png){kind=logo}
